We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

Back to rankings

265 hedge funds and large institutions have $997M invested in Avanos Medical in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 78 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $541K | Put options by funds: $118K

17% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 35

13% more capital invested

Capital invested by funds: $884M → $997M (+$113M)

2.49% more ownership

Funds ownership: 93.14% → 95.63% (+2.5%)

2% more funds holding

Funds holding: 260 → 265 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 78

Holders
265
Holders Change
+5
Holders Change %
+1.92%
% of All Funds
3.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
41
Increased
67
Reduced
78
Closed
35
Calls
$541K
Puts
$118K
Net Calls
+$423K
Net Calls Change
+$438K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.1M
2
BlackRock
BlackRock
New York
+$6.77M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$4.72M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$4.66M
5
RC
RGM Capital
Florida
+$4.54M

Top Sellers

Rank Fund Capital Flow
1
PIM
Paradice Investment Management
Colorado
-$12.8M
2
HA
Heartland Advisors
Wisconsin
-$3.76M
3
Invesco
Invesco
Georgia
-$2.54M
4
ECM
ExodusPoint Capital Management
New York
-$1.9M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
NB
226
NBT Bank
New York
$449 +$413 +20 New
RIM
227
Rockbridge Investment Management
New York
$427 +$392 +19 New
SPIA
228
Steward Partners Investment Advisory
New York
$426 -$516 -25 -57%
AA
229
Ancora Advisors
Ohio
$426 – – –
GIA
230
GHP Investment Advisors
Colorado
$404 – – –
HGA
231
Hobbs Group Advisors
South Carolina
$404 +$372 +18 New
GEA
232
Glen Eagle Advisors
New Jersey
$381 – – –
CPG
233
Cornerstone Planning Group
New Jersey
$336 – – –
GFPC
234
Global Financial Private Client
Florida
$336 – – –
CWC
235
Carolinas Wealth Consulting
North Carolina
$321 – – –
S
236
Sachetta
Massachusetts
$315 +$289 +14 New
FCA
237
FinTrust Capital Advisors
South Carolina
$292 – – –
CTA
238
Colonial Trust Advisors
South Carolina
$269 – – –
IPW
239
Impact Partnership Wealth
Georgia
$269 – – –
NFSG
240
Newbridge Financial Services Group
Florida
$269 – – –
RFG
241
RFP Financial Group
Georgia
$269 – – –
BWAM
242
Boyd Watterson Asset Management
Ohio
$247 – – –
BLC
243
Brown, Lisle/Cummings
Rhode Island
$247 – – –
AWM
244
AllSquare Wealth Management
New York
$202 – – –
PFBT
245
Parkside Financial Bank & Trust
Missouri
$202 +$186 +9 New
OLVIG
246
Oliver Lagore Vanvalin Investment Group
Michigan
$179 – – –
NECFA
247
New England Capital Financial Advisors
Connecticut
$135 -$62 -3 -33%
NFA
248
Northwest Financial Advisors
Virginia
$135 +$124 +6 New
GRP
249
Global Retirement Partners
California
$134 – – –
BMC
250
Bear Mountain Capital
Washington
$115 +$124 +6 New
8 9
10
11 12

AVNS Hedge Fund Activity: Q4 2023 in Review

265 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2023, worth a combined $997M — up 13% from $884M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new AVNS positions and 35 closed out — a net gain of 6 holders — while 67 added to existing stakes and 78 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $10.1M. The largest seller was Paradice Investment Management, cutting an estimated $12.8M.

  • 265 institutional investors held Avanos Medical (AVNS) as of Q4 2023, up from 260 in Q3 2023.
  • Funds reported $997M of Avanos Medical stock for Q4 2023, up 13% quarter-over-quarter.
  • 41 funds opened new Avanos Medical positions in Q4 2023 and 35 closed out, a net change of +6 holders.
  • The largest Avanos Medical buyer in Q4 2023 was Morgan Stanley, an estimated $10.1M added.
  • The largest Avanos Medical seller in Q4 2023 was Paradice Investment Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2023.